NIOX Competitors and Similar CompaniesClear all
Zogenix's competitors and similar companies include Durect and Sucampo Pharmaceuticals.
 Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. | |
Founding Date | Founding Date 2006 | Founding Date N/A | Founding Date 1996 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Cupertino, US HQ | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB |
Employees | Employees 743% increase | Employees 902% increase | Employees 37 |
Financial | |||
Revenue (est.) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) $230.1m (FY, 2016) |
Cost of goods | Cost of goods $4.8m (FY, 2021) | Cost of goods $78k (FY, 2024) | Cost of goods $76m (FY, 2016) |
Gross profit | Gross profit N/A | Gross profit $2m (FY, 2024) | Gross profit $154.1m (FY, 2016) |
Net income | Net income ($227.4m) (FY, 2021) | Net income ($8.3m) (FY, 2024) | Net income $18.5m (FY, 2016) |
For sources of this data, please see the company profile
View Company Profiles
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View companySucampo Pharmaceuticals
HQ
Rockville, US
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
View company